Oncidium foundation
Oncidium foundation
  • 15
  • 12 010
Episode 1: Nouvel espoir pour le cancer de la prostate : La RLT en Action - Focus Belgique
Ce premier épisode de la série RLT Channel est destiné aux personnes atteintes d'un cancer de la prostate et à leurs proches. Son objectif est de démystifier la thérapie par radioligands (RLT) en offrant des informations claires et pratiques, afin de vous aider à comprendre le fonctionnement de la thérapie, ses avantages potentiels et la manière dont elle peut être intégrée dans le parcours de soins. Qu'est-ce que la chaîne RLT ? La chaîne RLT est en train de devenir l'une de nos principales initiatives, offrant une plateforme récurrente pour mettre en lumière différents cancers et explorer leurs possibilités de traitement par radiothérapie. Chaque programme est conçu pour fournir des informations complètes, qu'il s'agisse de relever des défis mondiaux ou de mettre en lumière des perspectives et des avancées locales.
Переглядів: 10

Відео

Episode 1: Prostate Cancer’s New Hope: RLT in Action - Global focus
Переглядів 2327 годин тому
This first episode of the RLT Channel series is designed for individuals living with prostate cancer and their loved ones. Its goal is to demystify radioligand therapy (RLT) by offering clear and practical information, helping you understand how the therapy works, its potential benefits, and how it can be integrated into the care pathway. What's RLT Channel? The RLT Channel is evolving into one...
Ambassadors Meeting 2024
Переглядів 842 місяці тому
How can we support the development of #radiotheranostics and reach people living with cancer across borders? The answer is: Oncidium foundation Ambassadors. This team of #nuclearmedicine experts is committed to advance #radioligandtherapy for #cancercare, enabling local action with a global vision. We’re immensely grateful for their commitment and impact, and we look forward to welcoming new am...
John-Antoine, living with a prostate cancer and sharing his experience with radioligand therapy
Переглядів 9062 місяці тому
John-Antoine, living with a prostate cancer and sharing his experience with radioligand therapy
The remarkable journey of Mr. Adel, living with prostate cancer and undergoing lutetium therapy
Переглядів 2693 місяці тому
In this powerful video, we invite you to witness the remarkable journey of Mr. Adel, who is living with prostate cancer and undergoing Lutetium-177-PSMA therapy. As one of the first patients to benefit from RLT-Connect's dose donations, Mr. Adel's story reflects resilience and hope, from his initial diagnosis through the challenges of chemotherapy and hormone therapy, all in the pursuit of a br...
RLT-Connect - A Radioligand Therapy Dose Donation Platform
Переглядів 1235 місяців тому
The RLT-Connect platform is an online platform designed to facilitate collaboration between healthcare professionals seeking radioligand therapy for their patients who cannot afford it, and Radioisotope suppliers willing to donate doses to make this life-savings treatment accessible to those in need.
Donate for Hope !
Переглядів 41Рік тому
WE ARE 75% THERE! With radiopharmaceuticals suppliers and radiopharmacies' incredible support, we've secured 75% of our 2024 objectives, providing treatment for people living with cancer and facing financial challenges. HELP US AND DONATE TO GIVE THE FINAL PUSH!
ЧАСТЬ 2 - Доктор, я стану радиоактивным после курса тераностики?
Переглядів 112Рік тому
Что такое тераностинкологиика в онкологии? - ЧАСТЬ 2 - Вопросы и ответы (версия 2023 года) У вас есть вопросы о том, как работают средства тераностики? Вы пациент или общаетесь с пациентами, и вам необходимо ответить на конкретные вопросы? Это видео для вас. Смотрите вторую часть нашего иллюстрированного видеофильма и узнайте ответы на свои вопросы о тераностическом лечении рака Пропустили перв...
ЧАСТЬ 1 - Что такое тераностика в онкологии?
Переглядів 307Рік тому
Что такое тераностика? - ЧАСТЬ 1 (версия 2023 года) Вы все еще задаетесь вопросом, что такое тераностика? Как лучше описать онкопациенту что такое тераностика и как она работает. Посмотрите наш новый иллюстрированный видеоролик и узнайте больше о радиотераностике для лечения рака. Есть вопросы о самом лечении? Посмотрите наш второй видеоролик "Доктор, сделает ли меня тераностика радиоактивным? ...
Join the Tackle Cancer Challenge 2023!
Переглядів 41Рік тому
Want to boost your well-being while supporting the fight against cancer? From May 12th till May 28th, 2023, join our virtual race to bring forward radiotheranostics for cancer care! - Travel the world all together by covering a distance of 40 000 km, equivalent to a trip around the world - Practice your favorite sport and chose among a wide range of activities - Whomever and wherever you are, j...
PART 2 - Doctor, will radiotheranostics make me radioactive?
Переглядів 1,1 тис.2 роки тому
What are radiotheranostics for cancer care - PART 2 - Q&A (version 2023) Having some questions about how radiotheranostics work? Are you a patient or in contact with patients and need to answer specific questions? This video is for you. Watch the second part of our illustrated video and find out the answers to your questions about #radiotheranostics for #cancercare Missed the first video? Disco...
PART 1 - What are radiotheranostics for cancer care?
Переглядів 2,6 тис.2 роки тому
What are radiotheranostics for cancer care - PART 1 (2023 version) Still wondering what radiotheranostics are? Are you in contact with patients and wish to demonstrate how radiotheranostics work? Watch our new illustrated video and find out more about #radiotheranostics for #cancercare Any questions about the treatment itself? Watch our second video, "Doctor, will radiotheranostics make me radi...
2022 Version - PART 1 - What are radiotheranostics for cancer care?
Переглядів 1,7 тис.2 роки тому
Still wondering what radiotheranostics are? Are you in contact with patients and wish to demonstrate how radiotheranostics work? Watch our new illustrated video and find out more about #radiotheranostics for cancer care. Any questions about the treatment itself? Watch our second video, "Doctor, will radiotheranostics make me radioactive? - PART 2 - Q&A" on the Oncidium foundation youtube channe...
Fernando Acosta's Testimonial with Lutetium-177 PSMA Radioligand Therapy.
Переглядів 4,5 тис.2 роки тому
Discover Dr. Fernando Acosta’s treatment journey with radiotheranostics in his fight against prostate cancer. When he first found out about this new option, he did not care that it was impossible. After gathering more than 70 00 signatures and with the help of Dr. Maria Bastianello, Dr. Guillermo Casale and the Oncidium foundation, Fernando was treated with Lutetium-177 PSMA radioligand therapy...
Tom, treated with PRRT for NETs
Переглядів 3004 роки тому
Tom Bajoras is a composer, pianist, audio producer and Neuroendocrine Tumor (NET) patient. When Tom was diagnosed with a NET, he had no idea that the Peptide Receptor Radionuclide Therapy (PRRT) could save his life. In this video, Tom tells us his journey in his fight against a pancreatic tumor. PRRT is part of a technology called Radiotheranostics. To learn more about Radiotheranostics options...

КОМЕНТАРІ

  • @jean-lucvanderheyden1666
    @jean-lucvanderheyden1666 2 місяці тому

    Part 2 is as good as Part 1. Thank you for a great introductory video!!

  • @jean-lucvanderheyden1666
    @jean-lucvanderheyden1666 2 місяці тому

    Very well explained process of radiotheranostics!!!

  • @richardloren3098
    @richardloren3098 Рік тому

    Now approved by FDA in the USA and by NICE in the UK

  • @1royalpalm
    @1royalpalm Рік тому

    I'm 75-years-old. I had my prostate removed in 2018 after 12 biopsies revealed Gleason numbers of 7/8. After years of hormone treatment I finally became hormone refractory/resistant. I went on chemo (taxotere) for four cycles and my PSA continued to rise. I was then switched to jevtana and my PSA started to decline -- but inexplicably started to rise again after about 9 cycles. My oncologist sent me to a nuclear doctor that started me on Pluvicto (lutetium - 177). After the first cycle my PSA started to drop. After the second cycle my PSA dropped further. I've had my 3rd cycle but haven't got my PSA results yet, but I will get them when I start my 4th cycle this week (Oct. 24, 2023). Pluvicto is prohibitively expensive. My insurance company is billed $180K (US dollars) for each treatment! One thing I can attest to is that I have no negative side effects with Pluvicto, unlike chemo where I would get extreme fatigue, dry mouth, taste buds affected where food was unappealing, loss of hair. I'm scheduled for six cycles of Pluvicto. Just how much my PSA will drop and how long it will extend my life is to be determined.

  • @Orangestardust
    @Orangestardust Рік тому

    They need to make this treatment more available to people. Currently the only way men with a death sentence on their heads can receive this is through a clinical trial in the United States.

    • @taluaigaluega905
      @taluaigaluega905 Рік тому

      They will. It's on the final trial stage(3td). I'm part of the trial and I feel pretty good right now. At first I was not sure if this treatment was for me and at the end I said yes. I have four boys and brothers(3) and I'm 66 right so I decided to do it for them. This is for their if it works. But so far so good. I received the maximum of four doses or cycles. My last one was May 31, 2033. Keep finger cross.

    • @Nick-o5f
      @Nick-o5f 10 місяців тому

      How you fill now

  • @llewellynherbert3338
    @llewellynherbert3338 Рік тому

    Thank you for sharing with us your experience Fernando.I hope to have L.177 treatment soon.Keep on smiling.x

  • @cabshmUtube
    @cabshmUtube 2 роки тому

    Great explanation